| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/20/2014 | WO2014027006A1 Bioadhesive formulations for use in drug delivery |
| 02/20/2014 | WO2014026939A1 Stable pharmaceutical composition containing 8-[(3r)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1h-purine-2,6-dione or a pharmaceutically acceptable salt thereof |
| 02/20/2014 | WO2014026707A1 Anti-vaginitis compositions with improved release and adherence |
| 02/20/2014 | WO2014026656A1 Nanofiber structure with immobilized organic agens and the method of its preparation |
| 02/20/2014 | WO2014026557A1 Use of 3-amino-1-propanesulfonic acid and derivatives thereof in manufacture of medicaments for treatment of cardiovascular and cerebrovascular diseases or neurodegenerative diseases |
| 02/20/2014 | WO2014026457A1 Industrial preparation of natural killer cells (nks) and injection using human allogeneic karyocytes |
| 02/20/2014 | WO2014026284A1 Internal structured self assembling liposomes |
| 02/20/2014 | WO2014026254A1 Pharmaceutical formulations containing 3-(4-cinnamyl-l-piperazinyl) amino derivatives of 3-formylrifamycin sv and 3-formylrifamycin s and a process of their preparation |
| 02/20/2014 | WO2014026213A1 Antiseptic composition |
| 02/20/2014 | WO2014007972A9 Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinphrine |
| 02/20/2014 | WO2014002011A9 Micronized particles of olmesartan medoxomil and pharmaceutical composition thereof |
| 02/20/2014 | WO2013189467A3 Compounds from the fruits of acrocomia crispa and acrocomia aculeata against inflammation and oxidative stress |
| 02/20/2014 | WO2013177419A3 Lipid nanoparticle compositions and methods of making and methods of using the same |
| 02/20/2014 | WO2013175502A3 Formulations for mucosal administration |
| 02/20/2014 | WO2013175359A3 Compositions and methods for the treatment of multiple sclerosis |
| 02/20/2014 | WO2013163375A3 Implantable bioartificial perfusion system |
| 02/20/2014 | WO2013117742A3 Pharmaceutical composition for the treatment of multiple sclerosis |
| 02/20/2014 | WO2013005094A8 Acid addition salt of donepezil and pharmaceutical composition thereof |
| 02/20/2014 | WO2012156820A9 Intranasal testosterone bio-adhesive gel formulations and use thereof for treating male hypogonadism |
| 02/20/2014 | WO2012149045A3 Liposomal formulations |
| 02/20/2014 | US20140052175 High strength suture with absorbable core and suture anchor combination |
| 02/20/2014 | US20140052168 Methods of using in situ hydration of hydrogel articles for sealing or augmentation of tissue or vessels |
| 02/20/2014 | US20140052081 Donepezil transdermal patch |
| 02/20/2014 | US20140051770 Injectable multimodal polymer depot compositions and uses thereof |
| 02/20/2014 | US20140051767 Parenteral formulations of rasagiline |
| 02/20/2014 | US20140051761 Katp antagonists (glibenglamid) for use for promoting growth and/or treating hyperglycaemia of a premature infant |
| 02/20/2014 | US20140051733 Febuxostat pharmaceutical compositions |
| 02/20/2014 | US20140051717 Methods and systems for treatment of migraines and other indications |
| 02/20/2014 | US20140051690 Transnasal Anticonvulsive Pharmaceutical Composition Comprising Poorly Soluble Anticonvulsant |
| 02/20/2014 | US20140051671 Pharmaceutical compositions |
| 02/20/2014 | US20140051670 Compositions Containing Moxifloxacin for Treating Otic Infections |
| 02/20/2014 | US20140051653 Topical application of ivermectin for the treatment of dermatological conditions/afflictions |
| 02/20/2014 | US20140051650 Vaginal compositions based on alkyl polyglucosides |
| 02/20/2014 | US20140051166 Method and medicament for inhibiting the expression of a given gene |
| 02/20/2014 | US20140050806 Method, Apparatus And Kit For The Treatment Of Neurodegenerative Diseases And Impairments |
| 02/20/2014 | US20140050799 Risperidone sustained release microsphere composition |
| 02/20/2014 | US20140050798 Sustained-release nanoparticle compositions and methods using the same |
| 02/20/2014 | US20140050797 Drug delivery systems comprising solid solutions of wealkly basic drugs |
| 02/20/2014 | US20140050796 Composition comprising a mixture of dextro- and levo- amphetamines complexed with ion-exchange resin particles to form drug resin particles |
| 02/20/2014 | US20140050795 Binder powders |
| 02/20/2014 | US20140050792 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent |
| 02/20/2014 | US20140050790 Triterpene-containing oleogel-forming agent, triterpene-containing oleogel and method for producing a triterpene-containing oleogel |
| 02/20/2014 | US20140050788 Micronized placental tissue compositions and methods of making and using the same |
| 02/20/2014 | US20140050787 Pharmaceutical compositions resistant to abuse |
| 02/20/2014 | US20140050784 Pharmaceutical compositions of memantine |
| 02/20/2014 | US20140050782 Layered Bodies, Compositions Containing Them and Processes for Producing Them |
| 02/20/2014 | US20140050780 Liposomal formulation of nonglycosidic ceramides and uses thereof |
| 02/20/2014 | US20140050777 Liposomal Formulations of Polymyxin and Uses Thereof |
| 02/20/2014 | US20140050775 Polyamine Derivatives |
| 02/20/2014 | US20140050774 Wound treatment therapy |
| 02/20/2014 | US20140050773 Compound comprising alpha-msh for use in endodontic regeneration |
| 02/20/2014 | US20140050772 Methods for treating conditions of the nail unit |
| 02/20/2014 | US20140050771 Pdgf induced cell homing |
| 02/20/2014 | US20140050767 Epidermal cooling |
| 02/20/2014 | US20140050766 Tissue engineering construct comprising fibrin |
| 02/20/2014 | US20140050765 Devices and Methods for Tissue Engineering |
| 02/20/2014 | US20140050718 Methods and Compositions for Enhancing Intranasal Delivery of Therapeutic Agents |
| 02/20/2014 | US20140050673 Oil-Based Foamable Carriers And Formulations |
| 02/20/2014 | US20140050671 Theranostic nanoparticle and methods for making and using the nanoparticle |
| 02/20/2014 | US20140050666 Scavenger receptor uptake for fabry disease enzyme replacement therapy |
| 02/19/2014 | EP2698341A2 Continuous method for producing nanoparticles and nanoparticles obtained by means of said method |
| 02/19/2014 | EP2698168A1 Paliperidone Oral Solution |
| 02/19/2014 | EP2698155A1 Pharmaceutical unit dosage form comprising 4-phenylbutyric acid |
| 02/19/2014 | EP2698151A1 Orally Disintegrating Formulation of Paliperidone |
| 02/19/2014 | EP2698150A1 Oral solid preparation of compound antituberculosis drug and preparation method thereof |
| 02/19/2014 | EP2698149A1 Topical Aqueous Pharmaceutical Compositions of Flurbiprofen and Chlorhexidine |
| 02/19/2014 | EP2698148A1 Chewing Gum Formulations Comprising Dapoxetine and Tadalafil |
| 02/19/2014 | EP2698147A1 Oral Film Formulations Comprising Dapoxetine and Tadalafil |
| 02/19/2014 | EP2698146A1 Tablet Formulations Comprising Tadalafil and Dapoxetine |
| 02/19/2014 | EP2698145A1 Pharmaceutical Formulations comprising dapoxetine and a PDE5 inhibitor |
| 02/19/2014 | EP2698144A1 Prolonged release gabapentin tablet formulation whose ability to stay in the stomach is improved |
| 02/19/2014 | EP2697520A2 Capsules comprising an emulsified syrup and methods of making the same |
| 02/19/2014 | EP2696887A2 Redox responsive polymeric nanocapsules for protein delivery |
| 02/19/2014 | EP2696876A1 Aqueous ophthalmic composition |
| 02/19/2014 | EP2696875A1 Methods for treating bacterial infection |
| 02/19/2014 | EP2696858A2 Unit dose form for oral administration |
| 02/19/2014 | EP2696857A1 Pharmaceutical composition comprising bosentan |
| 02/19/2014 | EP2696856A1 Controlled-release formulation comprising hcg |
| 02/19/2014 | EP2696855A1 Coated mesoporous nanoparticles |
| 02/19/2014 | EP2696854A1 Febuxostat solid dispersion |
| 02/19/2014 | EP2696853A1 Surface induced disassembly of nano containers |
| 02/19/2014 | EP2696852A1 System and method for multiphasic release of growth factors |
| 02/19/2014 | EP2696851A1 Multilayer thin film drug delivery device and methods of making and using the same |
| 02/19/2014 | EP2696850A1 Dual lane coating |
| 02/19/2014 | EP2696848A1 Freeze dried drug nanosuspensions |
| 02/19/2014 | EP2696847A1 Fatty acid acylated amino acids for oral peptide delivery |
| 02/19/2014 | EP2696846A1 Oral pharmaceutical dispersion compositions |
| 02/19/2014 | EP2696705A1 Encapsulation system for protection of probiotics during processing |
| 02/19/2014 | EP2696684A1 Solid pharmaceutical composition |
| 02/19/2014 | CN203436580U Smooth slimming capsule structure capable of preventing and treating obesity and promoting micro-lipid metabolism |
| 02/19/2014 | CN1980637B Liposomes useful for drug delivery |
| 02/19/2014 | CN103596598A Dressings and related methods therefor |
| 02/19/2014 | CN103596572A Aqueous ophthalmic composition |
| 02/19/2014 | CN103596571A Methods for treating insomnia |
| 02/19/2014 | CN103596565A The use of secnidazole in treating dental infections |
| 02/19/2014 | CN103596560A Sheet and liquid combination systems for dermal drug delivery |
| 02/19/2014 | CN103596559A Nanoparticle compositions, formulations thereof, and uses therefor |
| 02/19/2014 | CN103596558A Nanocapsules with a polymer shell |
| 02/19/2014 | CN103596557A Freeze-dried aripiprazole formulation |
| 02/19/2014 | CN103596556A Rapid dissolve tablet compositions for vaginal administration |